Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potein inhibitor of insulin receptor than IGF-I receptor

This publication has 22 references indexed in Scilit:

• The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin
  Biochemical Journal, 1988
• Specificity of tyrosine protein kinases of the structurally related receptors for insulin and insulin-like growth factor I: Tyr-containing synthetic polymers as specific inhibitors or substrates
  Archives of Biochemistry and Biophysics, 1988
• Epidermal growth factor receptor tyrosine kinase phosphorylation of glucose-6-phosphate dehydrogenase in vitro
  Archives of Biochemistry and Biophysics, 1987
• After Insulin Binds
  Science, 1987
• Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60.
  The Journal of Antibiotics, 1987
• Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
  Biochemical and Biophysical Research Communications, 1986
• The effect of quercetin on the phosphorylatio activity of the Rous sarcoma virus transforming gene product in vitro and in vivo
  European Journal of Biochemistry, 1983
• Selective inhibition of a cyclic nucleotide independent protein kinase (G type casein kinase) by quercetin and related polyphenols
  Biochemical Pharmacology, 1982
• A new alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization.
  The Journal of Antibiotics, 1977
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970